MedTrace Logo

A Prospective Registry For Patients With Non-Tuberculous Mycobacterial (NTM) Pulmonary Disease in Korea.

NCT03934034 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2019-05-01

No results posted yet for this study

Summary

The incidence and prevalence of pulmonary disease due to Non-tuberculous mycobacteria (NTM) is increasing worldwide, and this trend has been confirmed in Korea. Treatment of NTM pulmonary disease is difficult and usually requires more than two years of long-term treatment, and the antibiotic regimens used in treatment vary. Therefore, it is difficult to track the natural history of patients with NTM pulmonary disease, to evaluate the treatment outcome, and to understand the effect of specific medicines on the outcome. Establishing a prospective registry of patients with NTM pulmonary disease is expected to accurately evaluate the progress, treatment modality, and treatment outcome of NTM pulmonary disease.

Conditions

  • Pulmonary Disease
  • Pulmonary Infection
  • Non-Tuberculous Mycobacterial Pneumonia

Sponsors & Collaborators

  • Asan Medical Center

    collaborator OTHER

  • Samsung Medical Center

    collaborator OTHER

  • Pusan National University Hospital

    collaborator OTHER

  • Severance Hospital

    collaborator OTHER

  • Pusan National University Yangsan Hospital

    collaborator OTHER

  • Chonnam National University Hospital

    collaborator OTHER

  • Korean Institute of Tuberculosis

    collaborator OTHER

  • International Tuberculosis Research Center

    collaborator OTHER

  • Seoul National University Hospital

    lead OTHER

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-30
Primary Completion
2029-12-31
Completion
2029-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03934034 on ClinicalTrials.gov